Categories AlphaGraphs, Earnings, Health Care
VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also provided guidance for fiscal 2023.
September-quarter earnings, adjusted for special items, moved up to $4.08 per share from $4.01 per share in the same period of 2022. Unadjusted profit was $1.04 billion or $3.97 per share, vs. $930.5 million or $3.59 per share a year earlier.
The company said that third-quarter revenues increased to $2.48 billion from $2.33 billion in the year-ago period. For the whole of fiscal 2023, the management expects total product revenues to be in the range of $9.85 billion.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Target (TGT) expected to report lower Q3 2025 sales and profit
Target Corporation (NYSE: TGT) is navigating a challenging retail landscape ahead of next week's earnings, as sales and margins face pressure from economic uncertainty and restrained consumer demand. With a
Home Depot (HD) expected to report higher revenue and earnings in Q3 2025
Shares of The Home Depot (NYSE: HD) dipped over 1% on Monday. The stock has dropped 5% in the past three months. The home improvement retailer is scheduled to report
Tyson Foods (TSN) Q4 2025 adj. earnings beat unexpectedly; sales up 2%
Tyson Foods, Inc. (NYSE: TSN), a leading processor and marketer of chicken, beef, and pork, reported stronger-than-expected earnings for the fourth quarter of fiscal 2025 when the company's sales rose
